<?xml version="1.0" encoding="utf-8" ?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Medicinecounter - Latest News</title>
<link href="https://news.prfree.org/rss/medicinecounter/latest.xml"></link>
<updated>2026-07-22T00:40:58+00:00</updated>
<id>urn:uuid:efad379c-f86a-c509-57dd-6e7331c0e3ef</id>
<entry>
<title>Ivermectin Remains in Global Focus as U.S. Patients Seek Clear Guidance and Licensed Access</title>
<link href="https://news.prfree.org/@medicinecounter/ivermectin-remains-in-global-focus-as-us-patients-seek-clear-guidance-and-licensed-access-x3bdkr95cx0n"></link>
<id>urn:uuid:f556461e-0166-6f35-a872-9e0d3e65e470</id>
<summary type="html"><![CDATA[Ivermectin’s Nobel Prize history and global research attention continue to spark public interest. U.S. patients seek licensed, legal access for its FDA-approved antiparasitic use.]]></summary>
<updated>2025-12-08T15:13:07+00:00</updated>
</entry>
<entry>
<title>Ivermectin’s Online Evolution: A Decade of Debate, Discovery, and Renewed Interest</title>
<link href="https://news.prfree.org/@medicinecounter/ivermectin-s-online-evolution-a-decade-of-debate-discovery-and-renewed-interest-7gvskf3g1yib"></link>
<id>urn:uuid:041e1a42-970a-a05c-e025-1a81394eaa77</id>
<summary type="html"><![CDATA[Ivermectin has gained ongoing attention across social media due to its Nobel Prize history and medical background. Medicine Counter provides clear, verified information and responsible access for prescribed uses.]]></summary>
<updated>2025-11-26T15:03:37+00:00</updated>
</entry>
</feed>